Osiris/Genzyme Put Stem Cells On The Deal Map

First-in-class MSC-based therapy Prochymal headed to regulators in 2009 for GvHD.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet